SEIDENBERG BETH C
CIK: 0001184592
Director10% Owner
Primary company: Progyny, Inc. (PGNY)
SEIDENBERG BETH C is a corporate insider at Progyny, Inc. (PGNY) filing SEC Form 4 transactions. 286 transactions across 11 companies, totaling $83,695,357 in purchases and $15,954,452 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Latigo Biotherapeutics, Inc. LTGO | Conversion | 165,519 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 2,066,857 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 1,484,401 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 3,464,072 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 1,027,635 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 3,547,842 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 938,979 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 2,066,857 | - | - | 2,094,813 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 165,519 | - | - | 5,160,847 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 1,484,401 | - | - | 4,995,328 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 3,464,072 | - | - | 3,510,927 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 1,027,635 | - | - | 5,944,009 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 3,547,842 | - | - | 4,916,374 | 8/10/2026 Filed: 8/10/2026 | Filing → |
Latigo Biotherapeutics, Inc. LTGO | Conversion | 938,979 | - | - | 1,368,532 | 8/10/2026 Filed: 8/10/2026 | Filing → |
| Award | 39,567 | $6.48 | $256K | 39,567 | 6/12/2026 Filed: 6/12/2026 | Filing → | |
| Award | 17,084 | $34.35 | $587K | 17,084 | 5/21/2026 Filed: 5/21/2026 | Filing → | |
| Purchase | 133,333 | $7.50 | $1000K | 869,317 | 12/18/2025 Filed: 12/22/2025 | Filing → | |
| Award | 32,250 | - | - | 32,250 | 6/9/2025 Filed: 6/10/2025 | Filing → | |
| Award | 28,522 | - | - | 28,522 | 6/6/2025 Filed: 6/10/2025 | Filing → | |
| Award | 65,351 | - | - | 65,351 | 5/29/2025 Filed: 6/2/2025 | Filing → |
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
165,519
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
2,066,857
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
1,484,401
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
3,464,072
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
1,027,635
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
3,547,842
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
938,979
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
2,066,857
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
165,519
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
1,484,401
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
3,464,072
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
1,027,635
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
3,547,842
Price
-
Value
-
Latigo Biotherapeutics, Inc.
LTGO
Type
Conversion
Shares
938,979
Price
-
Value
-
Type
Award
Shares
39,567
Price
$6.48
Value
$256K
Type
Award
Shares
17,084
Price
$34.35
Value
$587K
Type
Purchase
Shares
133,333
Price
$7.50
Value
$1000K
Type
Award
Shares
32,250
Price
-
Value
-
Type
Award
Shares
28,522
Price
-
Value
-
Type
Award
Shares
65,351
Price
-
Value
-
AI Agent
Try asking...